Scipher Medicine and Roivant Sciences today announced a strategic partnership to advance rheumatology drug discovery and development by integrating Scipher’s real-world clinical and genomic data insights into Roivant’s research and development efforts. This collaboration will leverage Scipher's unique data and intelligence derived from its PrismRA precision medicine diagnostic. ? Scipher's PrismRA test uses 19 genomic markers to identify patients who are unlikely to respond to specific rheumatoid arthritis therapies, enabling personalized treatment decisions. By integrating data and insights derived from the development and commercialization of PrismRA, Roivant will leverage a unique and powerful data asset to inform its drug development pipeline. Link: https://lnkd.in/eWUdP8Gz #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis #RealWorldEvidence #ArtificialIntelligence
Scipher Medicine
生物技术研究
Waltham，Massachusetts 28,851 位关注者
Scipher Medicine is a precision immunology company matching each patient with their most effective therapy.
关于我们
Scipher Medicine is building the future of patient treatment.
Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
- 网站
-
https://www.sciphermedicine.com
Scipher Medicine的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Waltham，Massachusetts
- 类型
- 私人持股
- 创立
- 2015
- 领域
- network science、network medicine、data science、diagnostics、 drug response prediction、 drug development、complex diseases、autoimmune diseases、biomarkers、machine learning、gene expression、rheumatoid arthritis、IBD、ulcerative colitis和precision medicine
地点
-
主要
获取路线
500 Totten Pond Rd
US，Massachusetts，Waltham，02451
Scipher Medicine员工
动态
-
Scipher Medicine and OMNY Health today announced a partnership to advance precision medicine efforts for immunology. This collaboration marks a significant leap forward in the fight against autoimmune diseases, integrating transcriptomic data from Scipher with OMNY Health's vast EHR network that reaches more than 80 million patients. OMNY Health’s network includes data from nearly 250,000 patients with rheumatoid arthritis (RA), which enables comprehensive tracking of patient outcomes and disease progression. ? This partnership unlocks a wealth of information for researchers and drug developers. By combining the detailed clinical data within OMNY Health's network with the rich genomic insights from PrismRA, a personalized blood test for RA, researchers may gain a holistic view of the patient journey. This deeper understanding will fuel the development of more targeted therapies and improve overall patient outcomes. ? #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis #TargetedTherapy #RealWorldEvidence #ArtificialIntelligence https://lnkd.in/e825Xqp4
-
Scipher Medicine and Atropos Health announced a strategic partnership to accelerate precision medicine and expand the Immunology Multimodal Network, advancing shared decision-making for patients with rheumatoid arthritis. This collaboration will leverage Scipher's unique data and intelligence derived from its PrismRA precision medicine diagnostic and expand the Atropos Evidence? Network, enhancing the immunology multimodal network on Atropos Health’s GENEVA OS?. ? #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis #RealWorldEvidence #ArtificialIntelligence ? Link: https://lnkd.in/eESkfJTY
-
Scipher Medicine and Atropos Health announced a strategic partnership to accelerate precision medicine and expand the Immunology Multimodal Network, advancing shared decision-making for patients with rheumatoid arthritis. This collaboration will leverage Scipher's unique data and intelligence derived from its PrismRA precision medicine diagnostic and expand the Atropos Evidence? Network, enhancing the immunology multimodal network on Atropos Health’s GENEVA OS?. ? #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis #RealWorldEvidence #ArtificialIntelligence ? Link: https://lnkd.in/eESkfJTY
-
A new publication from Scipher Medicine in the Journal of Molecular Diagnostics details new approach to discover treatment-response-predicting biomarkers for complex diseases. #biomarkerdiscovery #networkmedicine https://lnkd.in/gpfCNwDZ
-
This week Scipher Medicine presented at EULAR 2024 in Vienna, Austria. The technology behind PrismRA and the impact that the test is having on treatment selection in RA is pushing precision medicine forward for autoimmune patients. #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis https://lnkd.in/gFGtqTRg
-
Scipher’s CEO & President, Reginald Seeto, CTO, Slava Akmaev, and Ingo Chakravarty are looking forward to joining over 500 public & private healthcare companies, investors, and VCs at this year’s Jefferies Global Healthcare Conference. #JefferiesHealthcare #PrecisionMedicine
-
-
Join us at BIO 2024 June 3-6 in San Diego, CA where Scipher’s executive leadership team will be meeting with leaders across the industry to showcase our unique Spectra Platform and the invaluable strides its making in precision medicine. #BIO2024 #PrecisionMedicine
-
-
This week Scipher’s own Uday Shankar Shanthamallu presented a poster at Digestive Disease Week in Washington DC. The research behind this poster continues to bring Scipher’s unique intelligence to precision medicine for treatment of autoimmune diseases such as Ulcerative Colitis. #PrecisonMedicine #AutoimmuneDisease #DDW2024 #ulcerativecolitis Link: https://lnkd.in/gb2smyT5
-
Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence. #ScipherMedicine #PrecisionMedicine #AutoimmuneDisease
-